Skip to main content

Advertisement

Table 1 Baseline characteristics of patients

From: Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study

CharacteristicsTotal
n%
Patients in population37100
Gender
 Male2773.0
 Female1027.0
Age (years)
 Patients with data37 
 Mean62.4 
 SD11.0 
 Median61.0 
 Range36–83 
Racial origin
 White3594.6
 Black25.4
Baseline ECOG
 03697.3
 112.7
Primary malignancies
 Bladder carcinoma12.7
 Breast cancer38.1
 Gastroesophageal junction12.7
 Malignant melanoma38.1
 Melanoma513.5
 Non-small-cell lung cancer821.6
 Pancreatic carcinoma12.7
 Prostate cancer1437.8
 Renal cell carcinoma12.7
  1. Subjects with missing baseline information are excluded from the corresponding analysis
  2. SD standard deviation